Home Covid News and Updates India reports 3,824 new COVID-19 cases in last 24 hours

India reports 3,824 new COVID-19 cases in last 24 hours

by Pragati Singh
covid

According to union health ministry data, a total of 3,824 new Covid-19 infections were registered across the country in the last 24 hours, a small increase from Saturday’s tally of 2994 coronavirus cases. India currently has 18,389 active Covid-19 cases. The 3,824 new coronavirus cases reported on Sunday represent the largest single-day increase in nearly six months.

According to today’s health bulletin, the daily positivity rate was 2.87 percent and the weekly positivity rate was 2.24 percent. The total number of patients who have recovered from the sickness is 4,41,73,335.

In the last 24 hours, a total of 2,799 Covid vaccine doses were provided. According to the ministry’s website, 220.66 crore doses of the Covid-19 vaccine have been distributed as part of the statewide vaccination campaign. In response to the recent spike in Covid-19 instances around the country, the Ministry of Health and Family Welfare has released amended instructions.

“Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other endemic infections must be considered. Systemic corticosteroids are not indicated in mild disease,” revised guidelines said.

“Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other endemic infections must be considered. Systemic corticosteroids are not indicated in mild disease,” revised guidelines said.

“Seek immediate medical attention if difficulty breathing, High-grade fever/ severe cough, particularly if lasting for more than 5 days. A low threshold is to be kept for those with any of the high-risk features,” guidelines discussed and prepared in January said.

Furthermore, “consider Remdesivir for up to 5 days (200 mg IV on day 1 followed by 100 mg IV OD for the next 4 days)” in moderate or severe conditions at high risk of advancement, according to the guidelines.

 

You may also like